Okamoto K, Tanaka H, Makino Y, Makino I
Second Department of Internal Medicine, Asahikawa Medical College, Nishikagura, Japan.
Biochem Pharmacol. 1998 Jul 1;56(1):79-86. doi: 10.1016/s0006-2952(98)00121-x.
We examined the effect of the novel antioxidant EPC-K1 (L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H -1-benzopyran-6-yl hydrogen phosphate] potassium salt) on glucocorticoid receptor function. We used cloned CHOpMTGR cells in which human glucocorticoid receptor cDNA was stably transfected and the glucocorticoid receptor was expressed at high levels. We recently suggested that glucocorticoid-mediated gene expression is modulated via the cellular redox state [Makino et al., J Clin Invest 98: 2469-2477, 1996]. In the present study, this issue was clearly evidenced by the finding that cellular treatment with H2O2 decreased the ligand binding and transcriptional activity of the glucocorticoid receptor, and we showed that these inhibitory effects of H2O2 were effectively titrated by the addition of EPC-K1. Moreover, DNA-binding activity of the bacterially expressed DNA-binding domain of the glucocorticoid receptor was repressed by the thiol-oxidizing reagent diamide; EPC-K1 also counteracted this repressive effect of diamide. Thus, the redox state was indicated to influence glucocorticoid receptor function at various steps, and EPC-K1 may be useful in restoring the cellular glucocorticoid-responsiveness in oxidative conditions.
我们研究了新型抗氧化剂EPC-K1(L-抗坏血酸2-[3,4-二氢-2,5,7,8-四甲基-2-(4,8,12-三甲基十三烷基)-2H-1-苯并吡喃-6-基磷酸氢盐]钾盐)对糖皮质激素受体功能的影响。我们使用了克隆的CHOpMTGR细胞,其中人糖皮质激素受体cDNA被稳定转染,且糖皮质激素受体高水平表达。我们最近提出糖皮质激素介导的基因表达是通过细胞氧化还原状态来调节的[牧野等,《临床研究杂志》98: 2469 - 2477, 1996]。在本研究中,这一问题通过以下发现得到了明确证明:用H2O2处理细胞会降低糖皮质激素受体的配体结合和转录活性,并且我们表明加入EPC-K1可有效中和H2O2的这些抑制作用。此外,糖皮质激素受体的细菌表达DNA结合结构域的DNA结合活性被硫醇氧化试剂二酰胺所抑制;EPC-K1也抵消了二酰胺的这种抑制作用。因此,氧化还原状态被表明在各个步骤影响糖皮质激素受体功能,并且EPC-K1可能有助于在氧化条件下恢复细胞对糖皮质激素的反应性。